104 related articles for article (PubMed ID: 26726140)
1. [Intestinal fatty acid binding protein: marker of enterocyte damage in acute and chronic gastroenterological diseases].
Kocsis D; Papp M; Tornai T; Tulassay Z; Herszényi L; Tóth M; Juhász M
Orv Hetil; 2016 Jan; 157(2):59-64. PubMed ID: 26726140
[TBL] [Abstract][Full Text] [Related]
2. The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases.
Ho SSC; Keenan JI; Day AS
Dig Dis Sci; 2020 Feb; 65(2):376-390. PubMed ID: 31529416
[TBL] [Abstract][Full Text] [Related]
3. Epithelial functions of the residual bowel after surgery for necrotising enterocolitis in human infants.
Schaart MW; de Bruijn AC; Bouwman DM; de Krijger RR; van Goudoever JB; Tibboel D; Renes IB
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):31-41. PubMed ID: 19458550
[TBL] [Abstract][Full Text] [Related]
4. Gut mucosal cell damage in meningococcal sepsis in children: relation with clinical outcome.
Derikx JP; Bijker EM; Vos GD; van Bijnen AA; Heineman E; Buurman WA; van Waardenburg DA
Crit Care Med; 2010 Jan; 38(1):133-7. PubMed ID: 19730255
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of gut barrier failure in the ICU.
Piton G; Capellier G
Curr Opin Crit Care; 2016 Apr; 22(2):152-60. PubMed ID: 26808138
[TBL] [Abstract][Full Text] [Related]
6. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP.
Derikx JP; Vreugdenhil AC; Van den Neucker AM; Grootjans J; van Bijnen AA; Damoiseaux JG; van Heurn LW; Heineman E; Buurman WA
J Clin Gastroenterol; 2009 Sep; 43(8):727-33. PubMed ID: 19359998
[TBL] [Abstract][Full Text] [Related]
7. Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study.
Schurink M; Kooi EM; Hulzebos CV; Kox RG; Groen H; Heineman E; Bos AF; Hulscher JB
PLoS One; 2015; 10(3):e0121336. PubMed ID: 25793701
[TBL] [Abstract][Full Text] [Related]
8. [Early diagnostic value of plasma and urine concentration of Intestinal fatty acid binding protein in gastrointestinal dysfunction or failure in the critically ill children].
Wang F; Zhu BQ; Xu D
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):712-3. PubMed ID: 18021569
[No Abstract] [Full Text] [Related]
9. Additional value of serum I-FABP levels for evaluating celiac disease activity in children.
Vreugdenhil AC; Wolters VM; Adriaanse MP; Van den Neucker AM; van Bijnen AA; Houwen R; Buurman WA
Scand J Gastroenterol; 2011 Dec; 46(12):1435-41. PubMed ID: 22029621
[TBL] [Abstract][Full Text] [Related]
10. Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine.
Gajda AM; Storch J
Prostaglandins Leukot Essent Fatty Acids; 2015 Feb; 93():9-16. PubMed ID: 25458898
[TBL] [Abstract][Full Text] [Related]
11. Intestinal fatty acid-binding protein levels in Necrotizing Enterocolitis correlate with extent of necrotic bowel: results from a multicenter study.
Heida FH; Hulscher JB; Schurink M; Timmer A; Kooi EM; Bos AF; Bruggink JL; Kasper DC; Pones M; Benkoe T
J Pediatr Surg; 2015 Jul; 50(7):1115-8. PubMed ID: 25783297
[TBL] [Abstract][Full Text] [Related]
12. Intestinal fatty acid-binding protein: a possible marker for gut maturation.
Reisinger KW; Elst M; Derikx JP; Nikkels PG; de Vries B; Adriaanse MP; Jellema RK; Kramer BW; Wolfs TG
Pediatr Res; 2014 Sep; 76(3):261-8. PubMed ID: 24956227
[TBL] [Abstract][Full Text] [Related]
13. Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality.
Piton G; Belon F; Cypriani B; Regnard J; Puyraveau M; Manzon C; Navellou JC; Capellier G
Crit Care Med; 2013 Sep; 41(9):2169-76. PubMed ID: 23782971
[TBL] [Abstract][Full Text] [Related]
14. Temporal profile of intestinal tissue expression of intestinal fatty acid-binding protein in a rat model of necrotizing enterocolitis.
Simões AL; Figueira RL; Gonçalves FL; Mitidiero LF; Silva OC; Peiró JL; Sbragia L
Clinics (Sao Paulo); 2016 Jul; 71(7):412-9. PubMed ID: 27464299
[TBL] [Abstract][Full Text] [Related]
15. Serum intestinal-fatty acid binding protein as a biomarker for refractory celiac disease.
Gross S; Adriaanse MP; Nijeboer P; Tack GJ; van Hoogstraten IM; Bouma G; Mulder CJ; von Blomberg BM; Vreugdenhil AC; Bontkes HJ
J Gastrointestin Liver Dis; 2015 Jun; 24(2):258-9. PubMed ID: 26114190
[No Abstract] [Full Text] [Related]
16. [Acute mesenteric ischemia: do biomarkers contribute to diagnosis?].
Rosero O; Harsányi L; Szijártó A
Orv Hetil; 2014 Oct; 155(41):1615-23. PubMed ID: 25282106
[TBL] [Abstract][Full Text] [Related]
17. Necrotizing enterocolitis is associated with neonatal intestinal injury.
Mannoia K; Boskovic DS; Slater L; Plank MS; Angeles DM; Gollin G
J Pediatr Surg; 2011 Jan; 46(1):81-5. PubMed ID: 21238645
[TBL] [Abstract][Full Text] [Related]
18. Smooth muscle actin as a novel serologic marker of severe intestinal damage in rat intestinal ischemia-reperfusion and human necrotising enterocolitis.
Evennett N; Cerigioni E; Hall NJ; Pierro A; Eaton S
J Surg Res; 2014 Oct; 191(2):323-30. PubMed ID: 24909869
[TBL] [Abstract][Full Text] [Related]
19. Enterocyte fatty acid uptake and intestinal fatty acid-binding protein.
Tso P; Nauli A; Lo CM
Biochem Soc Trans; 2004 Feb; 32(Pt 1):75-8. PubMed ID: 14748716
[TBL] [Abstract][Full Text] [Related]
20. Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis.
Gregory KE; Winston AB; Yamamoto HS; Dawood HY; Fashemi T; Fichorova RN; Van Marter LJ
J Pediatr; 2014 Jun; 164(6):1486-8. PubMed ID: 24636854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
